Comprehensive analysis of thiopurine S-methyltransferase phenotype–genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants

Elion, 1989, The purine path to chemotherapy., Science, 244, 41, 10.1126/science.2649979

Weinshilboum, 2001, Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase., Drug Metab Dispos, 29, 601

Krynetski, 2003, Drug methylation in cancer therapy: lessons from the TPMT polymorphism., Oncogene, 22, 7403, 10.1038/sj.onc.1206944

Weinshilboum, 1980, Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity., Am J Hum Genet, 32, 651

Otterness, 1997, Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms., Clin Pharmacol Ther, 62, 60, 10.1016/S0009-9236(97)90152-1

Yates, 1997, Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance., Ann Intern Med, 126, 608, 10.7326/0003-4819-126-8-199704150-00003

Krynetski, 1995, A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase., Proc Natl Acad Sci USA, 92, 949, 10.1073/pnas.92.4.949

Tai, 1996, Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians., Am J Hum Genet, 58, 694

Spire-Vayron de la Moureyre, 1998, Detection of known and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis., Hum Mutat, 12, 177, 10.1002/(SICI)1098-1004(1998)12:3<177::AID-HUMU5>3.0.CO;2-E

Hon, 1999, Polymorphism of the thiopurine S-methyltransferase gene in African-Americans., Hum Mol Genet, 8, 371, 10.1093/hmg/8.2.371

Colombel, 2000, Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy., Gastroenterology, 118, 1025, 10.1016/S0016-5085(00)70354-4

McLeod, 2002, The thiopurine S-methyltransferase gene locus - implications for clinical pharmacogenomics., Pharmacogenomics, 3, 89, 10.1517/14622416.3.1.89

Schaeffeler, 2003, A novel TPMT missense mutation associated with TPMT deficiency in a 5-year-old boy with ALL., Leukemia, 17, 1422, 10.1038/sj.leu.2402981

Hamdan-Khalil, 2003, In vitro characterization of four novel non-functional variants of the thiopurine S-methyltransferase., Biochem Biophys Res Commun, 309, 1005, 10.1016/j.bbrc.2003.08.103

Lindquist, 2004, Identification of two novel sequence variants affecting thiopurine methyltransferase enzyme activity., Pharmacogenetics, 14, 261, 10.1097/00008571-200404000-00006

McLeod, 1999, Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals., Pharmacogenetics, 9, 773, 10.1097/00008571-199912000-00012

Collie-Duguid, 1999, The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations., Pharmacogenetics, 9, 37, 10.1097/00008571-199902000-00006

Spire-Vayron de la Moureyre, 1999, Characterization of a variable number tandem repeat region in the thiopurine S-methyltransferase gene promoter., Pharmacogenetics, 9, 189

Alves, 2001, Influence of the variable number of tandem repeats located in the promoter region of the thiopurine methyltransferase gene on enzymatic activity., Clin Pharmacol Ther, 70, 165, 10.1067/mcp.2001.117284

Marinaki, 2003, Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype in British Asians and Caucasians., Pharmacogenetics, 13, 97, 10.1097/00008571-200302000-00006

Lennard, 1989, Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism., Clin Pharmacol Ther, 46, 149, 10.1038/clpt.1989.119

Schutz, 1993, Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient., Lancet, 341, 436, 10.1016/0140-6736(93)93028-Y

Schwab, 2001, Shortcoming in the diagnosis of TPMT deficiency in a patient with Crohn's disease using phenotyping only., Gastroenterology, 121, 498, 10.1053/gast.2001.26927

Evans, 2001, Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathio- prine., J Clin Oncol, 19, 2293, 10.1200/JCO.2001.19.8.2293

Black, 1998, Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine., Ann Intern Med, 129, 716, 10.7326/0003-4819-129-9-199811010-00007

Relling, 1999, Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus., J Natl Cancer Inst, 91, 2001, 10.1093/jnci/91.23.2001

Schwab, 2002, Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism., Pharmacogenetics, 12, 429, 10.1097/00008571-200208000-00003

Lennard, 2002, TPMT in the treatment of Crohn's disease with azathioprine., Gut, 51, 143, 10.1136/gut.51.2.143

Evans, 2002, Thiopurine S-methyltransferase: a genetic polymorphism that affects a small number of drugs in a big way., Pharmacogenetics, 12, 421, 10.1097/00008571-200208000-00001

Kaskas, 2003, Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine., Gut, 52, 140, 10.1136/gut.52.1.140

Krynetski, 2000, Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance., Pharmacology, 61, 136, 10.1159/000028394

Cheung, 2003, Mistaken identity: misclassification of TPMT phenotype following blood transfusion., Eur J Gastroenterol Hepatol, 15, 1245, 10.1097/00042737-200311000-00016

McLeod, 1995, Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia., Blood, 85, 1897, 10.1182/blood.V85.7.1897.bloodjournal8571897

Lennard, 1990, Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia., Lancet, 336, 225, 10.1016/0140-6736(90)91745-V

Woodson, 1983, Thiopurine methyltransferase. Aromatic thiol substrates and inhibition by benzoic acid derivatives., Mol Pharmacol, 24, 471

Szumlanski, 1995, Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine., Br J Clin Pharmacol, 39, 456, 10.1111/j.1365-2125.1995.tb04478.x

Lewis, 1997, Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drug-drug interaction., Clin Pharmacol Ther, 62, 464, 10.1016/S0009-9236(97)90125-9

Lowry, 2001, Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide., Gut, 49, 656, 10.1136/gut.49.5.656

Spire-Vayron de la Moureyre, 1998, Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population., Br J Pharmacol, 125, 879, 10.1038/sj.bjp.0702152

Loennechen, 2001, Detection of one single mutation predicts thiopurine S-methyltransferase activity in a population of Saami in northern Norway., Clin Pharmacol Ther, 70, 183, 10.1067/mcp.2001.117445

Rossi, 2001, Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects., Eur J Clin Pharmacol, 57, 51, 10.1007/s002280000246

Reis, 2003, Thiopurine methyltransferase phenotypes and genotypes in Brazilians., Pharmacogenetics, 13, 371, 10.1097/00008571-200306000-00009

Larovere, 2003, Genetic polymorphism of thiopurine S-methyltransferase in Argentina., Ann Clin Biochem, 40, 388, 10.1258/000456303766477039

Indjova, 2003, Phenotypic and genotypic analysis of thiopurine S-methyltransferase polymorphism in the Bulgarian population., Ther Drug Monit, 25, 631, 10.1097/00007691-200310000-00013

Conney, 2003, Induction of drug-metabolizing enzymes: a path to the discovery of multiple cytochromes P450., Annu Rev Pharmacol Toxicol, 43, 1, 10.1146/annurev.pharmtox.43.100901.135754

Bock, 1994, The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes., Pharmacogenetics, 4, 209, 10.1097/00008571-199408000-00005

Kroplin, 1998, Thiopurine S-methyltransferase activity in human erythrocytes: a new HPLC method using 6-thioguanine as substrate., Eur J Clin Pharmacol, 54, 265, 10.1007/s002280050457

Kroplin, 1999, Inhibition of thiopurine S-methyltransferase activity by impurities in commercially available substrates: a factor for differing results of TPMT measurements., Eur J Clin Pharmacol, 55, 285, 10.1007/s002280050630

McLeod, 1994, Thiopurine methyltransferase activity in American white subjects and black subjects., Clin Pharmacol Ther, 55, 15, 10.1038/clpt.1994.4

Weinshilboum, 1978, Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties., Clin Chim Acta, 85, 323, 10.1016/0009-8981(78)90311-X

Schaeffeler, 2001, High-throughput genotyping of thiopurine S-methyltransferase by denaturing HPLC., Clin Chem, 47, 548, 10.1093/clinchem/47.3.548

Weibull, 1951, A statistical distribution of wide applicability., Transact Am Soc Mech Eng: J Appl Mech, 73, 293

Moyer Ca, Bush, 1962, The Weibull distribution function for fatigue life., Mat Res Stand, 2, 405

Yamaoka, 1978, Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations., J Pharmacokin Biopharm, 6, 165, 10.1007/BF01117450

McDonald, 2002, Molecular haplotyping of genomic DNA for multiple single-nucleotide polymorphisms located kilobases apart using long-range polymerase chain reaction and intramolecular ligation., Pharmacogenetics, 12, 93, 10.1097/00008571-200203000-00003

Jacqz-Aigrain, 1994, Thiopurine methyltransferase activity in a French population: h.p.l.c. assay conditions and effects of drugs and inhibitors., Br J Clin Pharmacol, 38, 1, 10.1111/j.1365-2125.1994.tb04314.x

Weinshilboum, 1999, Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase., Annu Rev Pharmacol Toxicol, 39, 19, 10.1146/annurev.pharmtox.39.1.19

Yan, 2000, Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis., Clin Pharmacol Ther, 68, 210, 10.1067/mcp.2000.108674

Vuchetich, 1995, Segregation analysis of human red blood cell thiopurine methyltransferase activity., Genet Epidemiol, 12, 1, 10.1002/gepi.1370120102

Langley, 2002, Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis., J Hepatol, 37, 441, 10.1016/S0168-8278(02)00214-3

McLeod, 2000, Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia., Leukemia, 14, 567, 10.1038/sj.leu.2401723

Tai, 1997, Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT3A, TPMT2): mechanisms for the genetic polymorphism of TPMT activity., Proc Natl Acad Sci USA, 94, 6444, 10.1073/pnas.94.12.6444

Tai, 1999, Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT2, TPMT3A, TPMT3B or TPMT3C., Pharmacogenetics, 9, 641, 10.1097/01213011-199910000-00011

Klemetsdale, 1993, Gender difference in red blood cell thiopurine methyltransferase activity., Scand J Clin Lab Invest, 53, 747, 10.3109/00365519309092580

Szumlanski, 1992, Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes., Pharmacogenetics, 2, 148, 10.1097/00008571-199208000-00002

Tinel, 1991, Pharmacogenetics of human erythrocyte thiopurine methyltransferase activity in a French population., Br J Clin Pharmacol, 32, 729, 10.1111/j.1365-2125.1991.tb03981.x

Woodson, 1981, Rat thiopurine methyltransferase: regulation by testosterone., J Pharmacol Exp Ther, 218, 734

Panayiotidis, 2004, Cigarette smoke extract increases S-adenosylmethionine and cystathionine in human lung epithelial-like (A549) cells., Chem Biol Interact, 147, 87, 10.1016/j.cbi.2003.10.009

Pazmino, 1980, Thiol S-methylation in uremia: erythrocyte enzyme activities and plasma inhibitors., Clin Pharmacol Ther, 28, 356, 10.1038/clpt.1980.174